Stock CYTK CYTOKINETICS, INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

News Cytokinetics, Incorporated

Equities

CYTK

US23282W6057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-16 pm EDT 		5-day change 1st Jan Change
69 USD +1.47% Intraday chart for Cytokinetics, Incorporated -8.06% -17.36%
Apr. 09 Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing MT
Apr. 05 Sector Update: Health Care Stocks Rise Friday Afternoon MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
AQ
Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing
MT
Sector Update: Health Care Stocks Rise Friday Afternoon
MT
Cytokinetics Reports Positive Follow-On Data for Prospective Heart Medication; Shares Rise
MT
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
AQ
Cytokinetics Presents Additional 48-Week Data from Forest-Hcm, the Open Label Extension Clinical Study of Aficamten, At the American College of Cardiology 73rd Annual Scientific Session
CI
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
AQ
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session
AQ
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400 - Biotechnology
CI
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400 Health Care
CI
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400
CI
Cytokinetics, Incorporated(NasdaqGS:CYTK) dropped from S&P 600
CI
Cytokinetics, Incorporated(NasdaqGS:CYTK) dropped from S&P 600 Health Care
CI
Transcript : Cytokinetics, Incorporated Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09:00 AM
Mizuho Securities Adjusts Price Target on Cytokinetics to $99 From $103, Maintains Buy Rating
MT
Cytokinetics to Participate in March Investor Conferences
AQ
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
AQ
Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CYTK Stock
  4. News Cytokinetics, Incorporated